4.3 Article

Characterization of T-cell immunogenicity of two PE/PPE proteins of Mycobacterium tuberculosis

期刊

JOURNAL OF MEDICAL MICROBIOLOGY
卷 57, 期 9, 页码 1079-1086

出版社

MICROBIOLOGY SOC
DOI: 10.1099/jmm.0.47565-0

关键词

-

资金

  1. Indian Council for Medical Research, Government of India
  2. Colorado State University, USA
  3. National Institutes of Health
  4. National Institute of Allergy and Infectious Diseases [HHSN266200400091C]

向作者/读者索取更多资源

The PE and PPE proteins of Mycobacterium tuberculosis form a source of antigenic variation among different strains of this bacterium. Two of the PE_PGRS protein-encoding genes, rv3812 and rv3018c, are expressed in pathogenic mycobacteria and are implicated, respectively, in the persistence of the organism in macrophages and in virulence. Peptides derived from these proteins have been predicted to bind major histocompatibility complex (MHC) class I with high affinity on the basis of immunoinformatics analysis, suggesting a possible role for these proteins in antimycobacterial immunity. In the present work, using DNA constructs containing the rv3812 and rv3018c genes of M. tuberculosis, the immunogenicity of these proteins was demonstrated in BALE/c mice. Immunization with either DNA construct induced a significant number of CD8(+)-type T cells and a strong Th1-type response, with high gamma interferon (IFN-gamma) and low interleukin-4 responses. Three nonameric peptides of Rv3812 and two of Rv3018c elicited a strong T-cell response in an MHC-restricted manner. An epitope-specific response was demonstrated by the lysis of peptide-pulsed antigen-presenting cells, release of perforin and IFN-gamma production. Experimentally, these peptides bound with high affinity to MHC H-2K(d) and showed low dissociation rates of peptide-MHC complexes. This study suggests that the identified T-cell epitopes may contribute to immunity against tuberculosis if included in a vaccine.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据